Patents Assigned to AEPACT Limited
  • Cytotoxic drug therapy
    Patent number: 5658568
    Abstract: A compound comprises a target cell-specific portion, such as an antibody specific to tumour cell antigens, and an inactivating portion, such as an enzyme, capable of converting a substance which in its native state is able to inhibit the effect of a cytotoxic agent into a substance which has less effect against said cytotoxic agent. The prolonged action of a cytotoxic agent at tumour sites is therefore possible whilst protecting normal tissues from the effects of the cytotoxic agent.
    Type: Grant
    Filed: July 8, 1994
    Date of Patent: August 19, 1997
    Assignee: AEPACT Limited
    Inventor: Kenneth Dawson Bagshawe